|
AU2003200256B2
|
|
Generation of hematopoietic cells from multipotent neural stem cells
|
|
AU5393001A
|
|
Pretreatment with growth factors to protect against CNS damage
|
|
CA2307017A1
|
|
Erythropoietin-mediated neurogenesis
|
|
US6638501B1
|
|
Use of multipotent neural stem cell progeny to augment non-neural tissues
|
|
US6093531A
|
|
Generation of hematopoietic cells from multipotent neural stem cells
|
|
EP0941109A1
|
|
Pretreatment with growth factors to protect against cns damage
|
|
WO9735605A1
|
|
Manipulation of mitotically active cells of the hippocampal region of the brain
|
|
CA2204630A1
|
|
Regulation of neural stem cell proliferation
|
|
EP0792350A1
|
|
Regulation of neural stem cell proliferation
|
|
EP1130394A1
|
|
In vitro models of CNS function and dysfunction
|
|
US5980885A
|
|
Growth factor-induced proliferation of neural precursor cells in vivo
|
|
US5981165A
|
|
In vitro induction of dopaminergic cells
|
|
US6294346B1
|
|
Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
|
|
US7361505B1
|
|
Multipotent neural stem cell compositions
|
|
US6399369B1
|
|
Multipotent neural stem cell cDNA libraries
|
|
US6497872B1
|
|
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
|
US6071889A
|
|
In vivo genetic modification of growth factor-responsive neural precursor cells
|
|
US5750376A
|
|
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
|
|
US7166277B1
|
|
Remyelination of neurons using multipotent neural stem cell progeny
|
|
EP1298202A2
|
|
Biological factors and neural stem cells
|
